A moderate dose of pseudoephedrine does not alter muscle contraction strength or anaerobic power

Clinical Journal of Sport Medicine

Volumn 12, Issue 6, 2002, Pages 387-390

  Chu, Kelly S ^a   Doherty, Timothy J ^a   Parise, Gianni ^a   Milheiro, Jamie S ^a   Tarnopolsky, Mark A ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

Author keywords

Anaerobic exercise; Ergogenic aid; Fatigue

Indexed keywords

LACTIC ACID; PSEUDOEPHEDRINE; EPHEDRINE;

ADULT; ANAEROBIC CAPACITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EXERCISE; FEMALE; HAND GRIP; HUMAN; HUMAN EXPERIMENT; KNEE FUNCTION; LACTATE BLOOD LEVEL; MALE; MUSCLE CONTRACTION; MUSCLE FATIGUE; MUSCLE FORCE; MUSCLE FUNCTION; MUSCLE STRENGTH; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ANALYSIS OF VARIANCE; COMPARATIVE STUDY; CROSSOVER PROCEDURE; ENDURANCE; EXERCISE TEST; MUSCULOSKELETAL FUNCTION; PHYSIOLOGY; PROBABILITY; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY;

ADULT; ANALYSIS OF VARIANCE; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; EPHEDRINE; EXERCISE TEST; FEMALE; HUMANS; MALE; MUSCLE CONTRACTION; MUSCLE FATIGUE; MUSCULOSKELETAL PHYSIOLOGY; PHYSICAL ENDURANCE; PROBABILITY; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY;

EID: 0036864560     PISSN: 1050642X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042752-200211000-00011     Document Type: Article

References (15)

1. Empey DW, Young GA, Letley E, et al. Dose-response study of the nasal decongestant and cardiovascular effects of pseudoephedrine. Br J Clin Pharmacol 1980;9:351-358.
2. Taverner D, Danz C, Economos D. The effects of oral pseudoephedrine on nasal patency in the common cold: A double-blind single-dose placebo-controlled trial. Clin Otolaryngol 1999;24: 47-51.
3. Kumarnsit E, Harnyutianakorn P, Meksuriyen D, et al. Pseudoephedrine, a sympathomimetic agent, induces Fos-like immunoreactivily in rat nucleus accumbens and striatum, Neuropharmacology 1999;38:1381-1387.
4. Guyton AC, Hall JE. The autonomic nervous system [abstract]. Med Physiol 1996;777-780.
5. Kirby RF, Callahan MF, McCarty R, et al. Cardiovascular and sympathelic nervous system responses to an acule stressor in borderline hypertensive rats (BHR). Physiol Behav 1989;46:309-313.
6. Febbraio MA, Lambert DL, Starkie RL, et al. Effect of epinephrine on muscle glycogenolysis during exercise in trained men. J Appl Physiol 1998;84:465-470.
7. Gill ND, Shield A, Blazevich AJ, et al. Muscular and cardiorespiralory effects of pseudoephedrine in human athletes. Br J Clin Pharmacol 2000;50:205-213.
8. Gillies H, Derman WE, Noakes TD, et al. Pseudoephedrine is without ergogenic effects during prolonged exercise. J Appl Physiol 1996;81:2611-2617.
9. Clemons JM, Crosby SL. Cardiopulmonary and subjective effects of a 60 mg dose of pseudoephedrine on graded treadmill exercise. J Sports Med Phys Fitness 1993;33:405-412.
10. Bright TP, Sandage BW Jr, Fletcher HP. Selected cardiac and metabolic responses to pseudoephedrine with exercise. J Clin Pharmacol 1981;21:488-492.
11. Swain RA, Harsha DM, Baenziger J, et al. Do pseudoephedrine or phenylpropanolamine improve maximum oxygen uptake and time to exhaustion? Clin J Sport Med 1997;7:168-173.
12. Sidney KH, Leficoe NM. The effects of ephedrine on the physiological and psychological responses to submaximal and maximal exercise in man. Med Sci Sports 1977;9:95-99.
13. Bell DG, Jacobs L, Elleringlon K. Effect of caffeine and ephedrine ingestion on anaerobic exercise performance. Med Sci Sports Exerc 2001;33:1399-1403.
14. Bell DG, Jacobs I, Zamecnik J. Effects of caffeine, ephedrine and their combination on time to exhaustion during high-intensity exercise. Eur J Appl Physiol Occup Physiol 1998;77:427-433.
15. Tamopolsky MA, Roy BD, MacDonald JR. A randomized, controlled trial of creatine monohydrate in patients with mitochondrial cytopathies. Muscle Nerve 1997;20:1502-1509.